Briacell Therapeutics Corp. Common Shares BCTX
$3.44
+0.00%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-06-26 | View → |
| 10-Q | 10-Q | 2026-06-09 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 424B5 | 424B5 | 2026-06-02 | View → |
| 8-K | 8-K | 2026-03-31 | View → |
| 10-Q | 10-Q | 2026-03-10 | View → |
| 8-K | 8-K | 2026-03-09 | View → |
| 8-K | 8-K | 2026-02-20 | View → |
| DEF 14A | DEF 14A | 2026-02-12 | View → |
| 8-K | 8-K | 2026-01-15 | View → |
| 8-K | 8-K | 2025-12-29 | View → |
| S-1 | S-1 | 2025-12-23 | View → |
| 10-Q | 10-Q | 2025-12-11 | View → |
| 8-K | 8-K | 2025-12-01 | View → |
| 10-K | 10-K | 2025-10-16 | View → |
| 8-K | 8-K | 2025-08-26 | View → |
| 8-K | 8-K | 2025-07-16 | View → |
| S-1 | S-1 | 2025-07-08 | View → |
| 8-K | 8-K | 2025-06-18 | View → |
| 10-Q | 10-Q | 2025-06-16 | View → |
| 8-K | Current report (material event) | 2025-04-28 | View → |
| S-1 | IPO registration | 2025-04-22 | View → |
| 10-Q | Quarterly report | 2025-03-12 | View → |
| 8-K | Current report (material event) | 2025-03-12 | View → |
| 8-K | Current report (material event) | 2025-02-13 | View → |
| 8-K | Current report (material event) | 2025-02-06 | View → |
| 8-K | Current report (material event) | 2025-02-05 | View → |
| 424B5 | Prospectus supplement | 2025-02-04 | View → |
| 424B5 | Prospectus supplement | 2025-02-03 | View → |
| 8-K | Current report (material event) | 2025-01-28 | View → |
| 8-K | Current report (material event) | 2025-01-03 | View → |
| 8-K | Current report (material event) | 2025-01-03 | View → |
| DEF 14A | Proxy statement | 2024-12-17 | View → |
| 10-Q | Quarterly report | 2024-12-16 | View → |
| 8-K | Current report (material event) | 2024-12-16 | View → |
| 8-K | Current report (material event) | 2024-12-13 | View → |
| 424B5 | Prospectus supplement | 2024-12-12 | View → |
| 424B5 | Prospectus supplement | 2024-12-11 | View → |
| 8-K | Current report (material event) | 2024-11-25 | View → |
| 8-K | Current report (material event) | 2024-11-01 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $3.44
- Market Cap
- $29.93 million
- 52-Week Range
- $2.60 – $20.80
- Average Volume
- 136K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.